(Q34366551)

1 August 2017

Schizophrenia: Reconciliation of the dopamine, prostaglandin, and opioid concepts and the role of the pineal (English)

1 reference

1 August 2017

0 references

0 references

1

D F Horrobin

1 reference

1 August 2017

D. F. Horrobin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A85110

11 November 2022

language of work or name

English

0 references

publication date

1 March 1979

1 reference

1 August 2017

10 March 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=85110

full work available at URL

11 November 2022

https://api.elsevier.com/content/article/PII:S0140673679909486?httpAccept=text/xml

1 reference

10.1016/S0140-6736(79)90948-6

DOI

https://api.crossref.org/works/10.1016/S0140-6736(79)90948-6

https://api.elsevier.com/content/article/PII:S0140673679909486?httpAccept=text/plain

11 November 2022

1 reference

10.1016/S0140-6736(79)90948-6

DOI

https://api.crossref.org/works/10.1016/S0140-6736(79)90948-6

11 November 2022

1 reference

1 August 2017

1

1 reference

1 August 2017

529-531

1 reference

1 August 2017

8115

1 reference

Increased dopamine-receptor sensitivity in schizophrenia

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Naloxone-induced reversal of schizophrenic hallucinations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Increased CSF levels of endorphines in chronic psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Schizophrenia as a prostaglandin deficiency disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Prostaglandins and schizophrenia: further discussion of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Dopamine supersensitivity, endorphin excess, and prostaglandin E1 deficiency: three aspects of the same schizophrenic elephant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Effect of ADP on PGE1Formation in Blood Platelets from Patients with Depression, Mania and Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Reduced PGE1 stimulated 3H-cAMP accumulation in platelets from schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

A biochemical concept of mental disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Effect of penicillamine on schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Wheat Gluten as a Pathogenic Factor in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Increased IgA in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Prostaglandin E1 modifies nerve conduction and interferes with local anaesthetic action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Inhibition by morphine of prostaglandin-stimulated fluid secretion in rat jejunum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Morphine antagonises prostaglandin E1- mediated inhibition of human platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Morphine-like drugs inhibit the stimulation of E prostaglandins of cyclic AMP formation by rat brain homogenate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Neurotransmitter modulation of prostaglandin E1-stimulated increases in cyclic AMP. II. Characterization of a cultured neuronal cell line treated with dibutyryl cyclic AMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Narcotic dependence, narcotic action and dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

The nutritional and metabolic impact of gamma-linolenic acid (18:3omega6) on cats deprived of animal lipid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

The oxidative desaturation of unsaturated fatty acids in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Prostaglandin E1 treatment of NZB/NZW mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Penicillin and essential fatty acid supplementation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

Melatonin in Rat Pineal, Plasma, and Urine: 24-Hour Rhythmicity and Effect of Chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2990948-6

7 January 2021

10.1016/S0140-6736(79)90948-6

Identifiers

DOI

1 reference

1 August 2017

1 reference